Public company research profile

This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.

Open in CopyWindow

Company research history

Medpace Holdings, Inc. - Common Stock (MEDP)

Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.

17 disclosures
6 insiders
0 cluster signals
0.0% avg. 30d outcome

Company facts

Ticker / ISIN
MEDP / Not available
Exchange
Not available
Country
US
Sector
Not available

Disclosure history

David J. Taylor, Representative

buy disclosed on 28 May 2026 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Still fresh
Data Confidence
93%
Previous signal outcome
0.0%

David J. Taylor, Representative

buy disclosed on 28 May 2026 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Still fresh
Data Confidence
93%
Previous signal outcome
0.0%

David J. Taylor, Representative

buy disclosed on 6 Mar 2026 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Gilbert Cisneros, Representative

sell disclosed on 13 Feb 2026 via House STOCK Act disclosures

Transaction value
Not available
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

David J. Taylor, Representative

sell disclosed on 2 Feb 2026 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

David J. Taylor, Representative

buy disclosed on 2 Feb 2026 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Gilbert Cisneros, Representative

sell disclosed on 18 Nov 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Lisa McClain, Representative

sell disclosed on 12 Sept 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

David J. Taylor, Representative

sell disclosed on 2 Sept 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Gilbert Cisneros, Representative

sell disclosed on 14 Aug 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Lisa McClain, Representative

buy disclosed on 13 Aug 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Rob Bresnahan, Representative

sell disclosed on 13 Feb 2025 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

sell disclosed on 15 Aug 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

sell disclosed on 9 Jul 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

sell disclosed on 15 Feb 2024 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Michael Patrick Guest, Representative

buy disclosed on 11 Dec 2023 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%

Josh Gottheimer, Representative

sell disclosed on 29 Aug 2022 via House STOCK Act disclosures

Transaction value
1.001 US$
Copy Window
Probably too late
Data Confidence
93%
Previous signal outcome
0.0%
Medpace Holdings, Inc. - Common Stock (MEDP) public disclosure profile | CopyWindow